| Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, ... Nature medicine 14 (11), 1264-1270, 2008 | 1345 | 2008 |
| Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, ... Blood, The Journal of the American Society of Hematology 118 (23), 6050-6056, 2011 | 1297 | 2011 |
| Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes KCM Straathof, CM Bollard, U Popat, MH Huls, T Lopez, MC Morriss, ... Blood 105 (5), 1898-1904, 2005 | 455 | 2005 |
| Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells T Ara, L Song, H Shimada, N Keshelava, HV Russell, LS Metelitsa, ... Cancer research 69 (1), 329-337, 2009 | 206 | 2009 |
| CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases HV Russell, J Hicks, MF Okcu, JG Nuchtern Journal of pediatric surgery 39 (10), 1506-1511, 2004 | 142 | 2004 |
| Mental distress and health care use among survivors of adolescent and young adult cancer: a cross‐sectional analysis of the National Health Interview Survey S Kaul, JC Avila, M Mutambudzi, H Russell, AC Kirchhoff, CL Schwartz Cancer 123 (5), 869-878, 2017 | 114 | 2017 |
| Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report JM Su, XN Li, P Thompson, CN Ou, AM Ingle, H Russell, CC Lau, ... Clinical cancer research 17 (3), 589-597, 2011 | 114 | 2011 |
| Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature HS Smith, JM Swint, SR Lalani, JM Yamal, MC de Oliveira Otto, ... Genetics in Medicine 21 (1), 3-16, 2019 | 112 | 2019 |
| Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma X Shang, SM Burlingame, MF Okcu, N Ge, HV Russell, RA Egler, ... Molecular cancer therapeutics 8 (8), 2461-2469, 2009 | 112 | 2009 |
| Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma RA Egler, SM Burlingame, JG Nuchtern, HV Russell Clinical Cancer Research 14 (21), 7028-7034, 2008 | 70 | 2008 |
| Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children … SL Berg, MS Cairo, H Russell, J Ayello, AM Ingle, H Lau, N Chen, ... Journal of Clinical Oncology 29 (3), 316, 2011 | 69 | 2011 |
| Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma X Shang, SA Vasudevan, Y Yu, N Ge, AD Ludwig, CL Wesson, K Wang, ... Oncogene 29 (35), 4938-4946, 2010 | 67 | 2010 |
| Decision aids: when ‘nudging’patients to make a particular choice is more ethical than balanced, nondirective content JS Blumenthal-Barby, SB Cantor, HV Russell, AD Naik, RJ Volk Health Affairs 32 (2), 303-310, 2013 | 65 | 2013 |
| Needle core vs open biopsy for diagnosis of intermediate-and high-risk neuroblastoma in children SF Hassan, S Mathur, TJ Magliaro, EL Larimer, LB Ferrell, SA Vasudevan, ... Journal of pediatric surgery 47 (6), 1261-1266, 2012 | 55 | 2012 |
| A phase I study of zoledronic acid and low‐dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study HV Russell, SG Groshen, T Ara, YA DeClerck, R Hawkins, HA Jackson, ... Pediatric blood & cancer 57 (2), 275-282, 2011 | 52 | 2011 |
| Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin HV Russell, D Strother, Z Mei, D Rill, E Popek, E Biagi, E Yvon, M Brenner, ... Journal of immunotherapy 30 (2), 227-233, 2007 | 50 | 2007 |
| Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma A Mazloom, CU Louis, J Nuchtern, E Kim, H Russell, W Allen-Rhoades, ... International Journal of Radiation Oncology* Biology* Physics 90 (4), 858-862, 2014 | 48 | 2014 |
| Economic evaluation of pediatric cancer treatment: a systematic literature review HV Russell, J Panchal, H VonVille, L Franzini, JM Swint Pediatrics 131 (1), e273-e287, 2013 | 45 | 2013 |
| Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy H Russell, MJ Hicks, AA Bertuch, M Chintagumpala Pediatric blood & cancer 53 (1), 23-27, 2009 | 45 | 2009 |
| A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma HV Russell, D Strother, Z Mei, D Rill, E Popek, E Biagi, E Yvon, M Brenner, ... Journal of immunotherapy 31 (9), 812-819, 2008 | 40 | 2008 |
